Roche extends tender offer for Spark Therapeutics until May 2

|About: Spark Therapeutics, Inc. (ONCE)|By:, SA News Editor

Roche (OTCQX:RHHBY) has extended its offer for all of the outstanding common shares in Spark Therapeutics (NASDAQ:ONCE) from April 2 to May 2. About 11.3M shares, representing ~29.4% of Sparks' outstanding stock, have been tendered thus far.

Subscribe for full text news in your inbox